114 related articles for article (PubMed ID: 699629)
1. Gamma globulin therapy.
South MA
Cutis; 1978 Oct; 22(4):411, 428-9. PubMed ID: 699629
[No Abstract] [Full Text] [Related]
2. Uses and limitations of gammaglobulin therapy (literature review).
Sumarmo
Paediatr Indones; 1974; 14(9-10):174-84. PubMed ID: 4142072
[No Abstract] [Full Text] [Related]
3. [Antibody deficiency syndrome].
Schneeweiss B; Steinbrück P
Z Arztl Fortbild (Jena); 1971 May; 65(9-10):480-5. PubMed ID: 4107177
[No Abstract] [Full Text] [Related]
4. The place of the human gamma globulin in modern therapeutics.
Schless AP; Harell GS
Triangle; 1969; 9(2):74-8. PubMed ID: 4107076
[No Abstract] [Full Text] [Related]
5. [Substitution therapy in agammaglobulinemia].
Roord JJ; van der Meer JW
Ned Tijdschr Geneeskd; 1983 Aug; 127(32):1417-9. PubMed ID: 6621729
[No Abstract] [Full Text] [Related]
6. The assessment and management of primary antibody deficiency.
Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
[No Abstract] [Full Text] [Related]
7. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
Morell A; Barandun S
Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383
[No Abstract] [Full Text] [Related]
8. Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD.
Berger M
J Clin Immunol; 2011 Oct; 31(5):924-6. PubMed ID: 21643892
[TBL] [Abstract][Full Text] [Related]
9. A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency.
Med Lett Drugs Ther; 2015 Aug; 57(1476):121-2. PubMed ID: 26305523
[No Abstract] [Full Text] [Related]
10. Consensus on IVIG.
Lancet; 1990 Aug; 336(8713):470-2. PubMed ID: 1974993
[No Abstract] [Full Text] [Related]
11. [Intravenous gamma globulin therapy in Bruton's antibody deficiency syndrome].
Rossipal E
Wien Med Wochenschr; 1978 Apr; 128(8):240-3. PubMed ID: 77587
[No Abstract] [Full Text] [Related]
12. [Use of Immunoglobulins].
Franke F
Ther Ggw; 1972 Apr; 111(4):480-2 passim. PubMed ID: 5029713
[No Abstract] [Full Text] [Related]
13. [Primary defective immunopathies].
Salfner B
Internist (Berl); 1977 May; 18(5):248-54. PubMed ID: 326715
[No Abstract] [Full Text] [Related]
14. Prophylaxis and treatment of diseases by means of immunoglobulins.
Barandun S; Skvaril F; Morell A
Monogr Allergy; 1975; 9():39-60. PubMed ID: 123313
[No Abstract] [Full Text] [Related]
15. [Intravenous immunoglobulin administration for antibody deficiency (author's transl)].
Luthardt T
Dtsch Med Wochenschr; 1980 Jul; 105(28):993-7. PubMed ID: 7408694
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of intravenous gamma-globulin.
Barandun S; Morell A; Skvaril F
Bibl Haematol; 1980; (46):170-4. PubMed ID: 6155121
[No Abstract] [Full Text] [Related]
18. [Prevention and therapy with immunoglobulin SRK].
Schnoz M; Ryser DH; Barandun S; Eckmann L
Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
[TBL] [Abstract][Full Text] [Related]
19. Primary immune deficiency and replacement therapy.
Chapel M
Br J Hosp Med; 1988 Aug; 40(2):103. PubMed ID: 3167304
[No Abstract] [Full Text] [Related]
20. Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.
Matsumoto S; Kobayashi N; Gohya N
Eur J Pediatr; 1981 May; 136(2):167-71. PubMed ID: 6164555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
